NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome

Clinica Chimica Acta

Volumn 413, Issue 19-20, 2012, Pages 1525-1531

  Armstrong, Christopher W ^a,b   McGregor, Neil R ^c   Sheedy, John R ^a   Buttfield, Ian ^d   Butt, Henry L ^b,e   Gooley, Paul R ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Child Development Centre   (Australia)

^e Bioscreen   (Australia)

Author keywords

CFS; Chronic fatigue syndrome; Glucogenic amino acids; Glutamine; Metabolic profiling; Ornithine; Urea cycle

Indexed keywords

ALANINE; ASPARAGINE; ASPARTIC ACID; BIOLOGICAL MARKER; CREATININE; FORMIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; LEUCINE; LYSINE; ORNITHINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; VALINE;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; BLOOD SAMPLING; CHEMICAL PROCEDURES; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MALE; METABOLIC PROFILING; METABOLOMICS; NITROGEN METABOLISM; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FATIGUE SYNDROME, CHRONIC; FEMALE; GLUTAMINE; HUMANS; MALE; METABOLOME; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; ORNITHINE; UREA;

EID: 84863469037     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.06.022     Document Type: Article

References (40)

1. Wessely S. The epidemiology of chronic fatigue syndrome. Epidemiol Rev 1995, 17:139-151.
2. Carruthers B.M., Jain A.K., De Meirleir K.L., et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chron Fatigue Syndr 2003, 11:7-36.
3. Devanur L.D., Kerr J.R. Chronic fatigue syndrome. J Clin Virol 2006, 37:139-150.
4. Wyller V.B. The chronic fatigue syndrome - an update. Acta Neurol Scand Suppl 2007, 187:7-14.
5. Lombardi V.C., Ruscetti F.W., Das Gupta J., et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326:585-589.
6. Lo S.C., Pripuzova N., Li B., et al. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 2010, 107:15874-15879.
7. Erlwein O., Kaye S., McClure M.O., et al. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 2010, 5:e8519.
8. Sheedy J.R., Wettenhall R.E., Scanlon D., et al. Increased d-lactic acid intestinal bacteria in patients with chronic fatigue syndrome. In Vivo 2009, 23:621-628.
9. Patti G.J., Yanes O., Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012, 13:263-269.
10. Beger R.D., Colatsky T. Metabolomics data and the biomarker qualification process. Metabolomics 2012, 8:2-7.
11. Eaton K.K., Hunnisett A. Abnormalities in essential amino acids in patients with chronic fatigue syndrome. J Nutr Environ Med 2004, 14:95-101.
12. Jones M.G., Cooper E., Amjad S., Goodwin C.S., Barron J.L., Chalmers R.A. Urinary and plasma organic acids and amino acids in chronic fatigue syndrome. Clin Chim Acta 2005, 361:150-158.
13. McGregor N.R., Dunstan R.H., Zerbes M., Butt H.L., Roberts T.K., Klineberg I.J. Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome. Biochem Mol Med 1996, 58:85-92.
14. Niblett S.H., King K.E., Dunstan R.H., et al. Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome. Exp Biol Med (Maywood) 2007, 232:1041-1049.
15. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002, 1:153-161.
16. Beckonert O., Keun H.C., Ebbels T.M., et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2007, 2:2692-2703.
17. 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. Anal Chem 2006, 78:2199-2208.
18. Zhang S., Nagana Gowda G.A., Ye T., Raftery D. Advances in NMR-based biofluid analysis and metabolite profiling. Analyst 2010, 135:1490-1498.
19. Rocha C.M., Carrola J., Barros A.S., et al. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma. J Proteome Res 2011, 10:4314-4324.
20. Holmes E., Tsang T.M., Tabrizi S.J. The application of NMR-based metabonomics in neurological disorders. NeuroRx 2006, 3:358-372.
21. Dunn W.B., Goodacre R., Neyses L., Mamas M. Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook. Bioanalysis 2011, 3:2205-2222.
22. Gu H., Chen H., Pan Z., et al. Monitoring diet effects via biofluids and their implications for metabolomics studies. Anal Chem 2007, 79:89-97.
23. Teahan O., Gamble S., Holmes E., et al. Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem 2006, 78:4307-4318.
24. 1H nuclear magnetic resonance studies of water-soluble metabolites in blood and urine. Anal Biochem 2010, 398:263-265.
25. Efron B., Tibshirani R. An introduction to the bootstrap 1993, Chapman & Hall, New York.
26. Psychogios N., Hau D.D., Peng J., et al. The human serum metabolome. PLoS One 2011, 6:e16957.
27. Craig A., Cloarec O., Holmes E., Nicholson J.K., Lindon J.C. Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Anal Chem 2006, 78:2262-2267.
28. Couet C., Fukagawa N.K., Matthews D.E., Bier D.M., Young V.R. Plasma amino acid kinetics during acute states of glucagon deficiency and excess in healthy adults. Am J Physiol 1990, 258:E78-E85.
29. Erdmann N., Tian C., Huang Y., et al. In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage. J Neurochem 2009, 109:551-561.
30. Evans R.W., Fernstrom J.D., Thompson J., Morris S.M., Kuller L.H. Biochemical responses of healthy subjects during dietary supplementation with l-arginine. J Nutr Biochem 2004, 15:534-539.
31. Felig P., Marliss E., Ohman J.L., Cahill C.F. Plasma amino acid levels in diabetic ketoacidosis. Diabetes 1970, 19:727-728.
32. Yuneva M., Zamboni N., Oefner P., Sachidanandam R., Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 2007, 178:93-105.
33. Robertson M.J., Schacterle R.S., Mackin G.A., et al. Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression. Clin Exp Immunol 2005, 141:326-332.
34. Tirelli U., Marotta G., Improta S., Pinto A. Immunological abnormalities in patients with chronic fatigue syndrome. Scand J Immunol 1994, 40:601-608.
35. Leonard J.V., Morris A.A. Urea cycle disorders. Semin Neonatol 2002, 7:27-35.
36. Dettmer K., Aronov P.A., Hammock B.D. Mass spectrometry-based metabolomics. Mass Spectrom Rev 2007, 26:51-78.
37. Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids 2009, 37:1-17.
38. Rowbottom D.G., Keast D., Pervan Z., et al. The role of glutamine in the aetiology of the chronic fatigue syndrome: a prospective study. J Chron Fatigue Syndr 1998, 4:3-22.
39. Morris S.M. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 2002, 22:87-105.
40. Brosnan J.T., Brosnan M.E. Creatine metabolism and the urea cycle. Mol Genet Metab 2010, 100(Suppl. 1):S49-S52.